Taking advantage of ApoESA/SA mice, a new model combining both hypercholesterolemia and hypertension that rapidly develops atherosclerosis (manuscript under submission), we examined the impact of RIPK1 inhibition on advanced atherosclerosis. The gene discussed is RIPK1; the disease is Hypercholesterolemia.